Dapagliflozin plus calorie restriction for remission of type 2 diabetes: multicentre, double blind, randomised, placebo controlled trial.
Liu Y, Chen Y, Ma J, Lin J, Liu C, Li X, Xu Y, Kuang H, Shi L, Xue Y, Feng B, Zhu D, Wang G, Yang J, Xiao X, Yu X, Zhou J, Bao Y, Su Q, Lyu M, Li X, Zhang H, Li X.
Liu Y, et al. Among authors: xue y.
BMJ. 2025 Jan 22;388:e081820. doi: 10.1136/bmj-2024-081820.
BMJ. 2025.
PMID: 39843169
Clinical Trial.